These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1833809)

  • 1. Red man syndrome with teicoplanin.
    Dubettier S; Boibieux A; Lagable M; Crevon L; Peyramond D; Milon H
    Rev Infect Dis; 1991; 13(4):770. PubMed ID: 1833809
    [No Abstract]   [Full Text] [Related]  

  • 2. Teicoplanin in the treatment of infections caused by coagulase-negative staphylococci.
    Harding I; Garaud JJ
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():93-103. PubMed ID: 2965137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teicoplanin in infections caused by methicillin-resistant staphylococci.
    Drabu YJ; Walsh B; Blakemore PH; Mehtar S
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():89-92. PubMed ID: 2965136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teicoplanin in the treatment of skin and soft tissue infections.
    Turpin PJ; Taylor GP; Logan MN; Wood MJ
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():117-22. PubMed ID: 2965123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teicoplanin--domiciliary use in surgical infections.
    Rubinstein E
    Eur J Surg Suppl; 1992; (567):27-9. PubMed ID: 1381638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    Van Laethem Y; Hermans P; De Wit S; Goosens H; Clumeck N
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():81-7. PubMed ID: 2965135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of the use of teicoplanin for staphylococcal infections in immunocompetent and immunodepressed patients].
    Catania S; Trinchieri V; Lanzalone CM; Causo T; Allegra C; Catania N; Cirelli A
    Riv Eur Sci Med Farmacol; 1990 Dec; 12(6):319-24. PubMed ID: 2151886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic cross-reactivity of teicoplanin and vancomycin.
    McElrath MJ; Goldberg D; Neu HC
    Lancet; 1986 Jan; 1(8471):47. PubMed ID: 2867290
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of teicoplanin treatment associated with an increase in MIC during therapy of Staphylococcus aureus septicaemia.
    Manquat G; Croize J; Stahl JP; Meyran M; Hirtz P; Micoud M
    J Antimicrob Chemother; 1992 Jun; 29(6):731-2. PubMed ID: 1387135
    [No Abstract]   [Full Text] [Related]  

  • 10. Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.
    Galanakis N; Giamarellou H; Vlachogiannis N; Dendrinos C; Daikos GK
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):130-4. PubMed ID: 2968907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous drug reactions induced by glycopeptides].
    Prey S; Sparsa A; Boumediene A; Bonnetblanc JM; Weinbreck P; Denes E
    Med Mal Infect; 2007 May; 37(5):270-4. PubMed ID: 17434698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin administration in patients experiencing reactions to vancomycin.
    Smith SR; Cheesbrough JS; Makris M; Davies JM
    J Antimicrob Chemother; 1989 May; 23(5):810-2. PubMed ID: 2527221
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of teicoplanin for Hickman catheter associated staphylococcal infection in immunosuppressed patients.
    Webster A; Russell SJ; Souhami RL; Richards JD; Goldstone AH; Grüneberg RN
    J Hosp Infect; 1987 Jul; 10(1):77-82. PubMed ID: 2888816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
    LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D
    Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    Calain P; Krause KH; Vaudaux P; Auckenthaler R; Lew D; Waldvogel F; Hirschel B
    J Infect Dis; 1987 Feb; 155(2):187-91. PubMed ID: 2949024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerance of teicoplanin in postoperative infections caused by gram-positive microorganisms].
    Alberghina A; Romeo B; Pessione E; Mauri A; Enrichens F; Sciascia C; Olivero G
    Minerva Chir; 1987 Sep; 42(17):1339-45. PubMed ID: 2959879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Teicoplanin in otorhinolaryngology].
    Cavallo GP; Malcangi A
    G Batteriol Virol Immunol; 1986; 79(7-12):250-7. PubMed ID: 2969345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
    Cunningham R
    J Antimicrob Chemother; 1992 Apr; 29(4):459-6. PubMed ID: 1535069
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of teicoplanin in localized experimental infections in rats.
    Arioli V; Berti M; Candiani G
    J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulase-negative staphylococci emerging during teicoplanin therapy and the determination of their sensitivity.
    Jones RN
    J Antimicrob Chemother; 1992 Jun; 29(6):725-7. PubMed ID: 1387134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.